Trial Profile
Immunogenicity and safety of influenza vaccine in psoriatic arthritis patients treated with secukinumab
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary) ; Methotrexate
- Indications Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- 26 Nov 2018 New trial record
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting